Cover Image
市場調查報告書

電腦支援診斷 (CADx)的全球市場:市場預測 (各用途、顯像模式、各國)、專利環境、市場佔有率、競爭環境

Global Computer Aided Diagnostics (CADx) Market - Analysis and Forecast 2017-2025: Focus on Application, Imaging Modalities, Country Analysis, Patent Landscape, Market Share Analysis and Competitive Landscape

出版商 BIS Research 商品編碼 529931
出版日期 內容資訊 英文 339 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
電腦支援診斷 (CADx)的全球市場:市場預測 (各用途、顯像模式、各國)、專利環境、市場佔有率、競爭環境 Global Computer Aided Diagnostics (CADx) Market - Analysis and Forecast 2017-2025: Focus on Application, Imaging Modalities, Country Analysis, Patent Landscape, Market Share Analysis and Competitive Landscape
出版日期: 2017年07月18日 內容資訊: 英文 339 Pages
簡介

本報告提供全球電腦支援診斷 (CADx)的市場調查,市場及技術概要,市場成長的各種影響因素及市場機會分析,各產業、技術、企業趨勢,用途、顯像模式、地區/主要國家趨勢與市場規模的變化與預測,以及主要企業的簡介等彙整。

摘要整理

第1章 調查範圍、調查手法

第2章 市場概要

  • 簡介
  • 市場趨勢
  • CAD的評估法
  • CADx的深度學習
  • CADx的深度學習的需求
  • CAD的優點
  • CADx深度學習演算法的廣泛引進的抑制因素
  • CADx:近幾年的發展趨勢

第3章 市場動態

  • 概要
  • 市場促進因素
  • 市場成長的阻礙因素
  • 市場課題
  • 市場機會

第4章 競爭環境

  • 市場主要發展趨勢
    • 新產品的投入、開發、實驗
    • 專利、核准、認證
    • M&A
    • 聯盟、合資企業、聯盟
    • 產業擴張
    • 其他 策略
  • 技術趨勢
  • 法律上的必要條件、各種法規
  • 供應鏈分析

第5章 產業分析

  • 專利環境
  • 協會、產業團體、規定當局

第6章 市場分析:各用途

  • 概要
  • 癌症
    • 乳癌
    • 肺癌
    • 大腸癌
    • 前列腺癌
    • 肝癌
    • 其他
  • 其他

第7章 市場分析:各顯像模式

  • 概要
  • 乳房X光攝影
  • MRI
  • 超音波
  • 斷層組合式
  • CT
  • 其他

第8章 市場分析:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 波蘭
    • 荷蘭
    • 瑞士
    • 奧地利
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 韓國
    • 澳洲
    • 印度
    • 其他
  • 其他
    • 巴西
    • 俄羅斯
    • 其他

第9章 企業簡介

  • Cadens Medical Imaging
  • EDDA Technology, Inc.
  • Fujifilm
  • GE Healthcare
  • Hologic Inc.
  • iCAD Inc.
  • Invivo Corporation
  • Koninklijke Philips N.V.
  • Median Technologies
  • Merge Healthcare Inc.
  • Neusoft Corporation
  • Parascript LLC
  • Riverain Technologies
  • Samsung Medison Co. Ltd.
  • Siemens Healthineers
  • Agfa Healthcare
  • McKesson Corporation
  • Xinapse Systems Ltd
目錄
Product Code: BH025A

The global computer aided diagnostics market is forecast to reach $XX million by 2025. The CADx market broadly focuses on major application areas (oncology, cardiovascular, and neurological) and various imaging modalities (mammography, MRI, tomosynthesis, etc.). The application segment of this market comprise of oncology and other diseases (neurological, cardiovascular and musculoskeletal) application areas.

The computer aided diagnostics (CAD) have emerged as one of the major potential tools in the medical imaging and diagnostic radiology. The performance and interpretation of diagnostic radiology test is a complex process, since handling and interpretation of the large volume of medical data and images can lead to increasing chances of interpretation errors by the radiologists. However, the solution to the prevention of these errors is the usage of computer aided diagnostics (CAD), along with several imaging modalities, in order to analyse and interpret medical images more accurately and precisely. The primary factors associated with the usage of CAD solutions are decreased false negative rate, accurate detection of cancer at an early stage, increased specificity and sensitivity of the diagnostics tests, improved intra- and inter-reader variability and reduced mortality rates.

This research study includes an extensive analysis of the global computer aided diagnostics (CAD) market, by application, diagnostics modalities and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. Each of these segments has been analyzed on the basis of their current and future market size, considering the macro and micro environmental factors.

The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of developments, trends and key market participants. While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section on competitive landscape, market share analysis, competitive benchmarking, and the position of the competitors within the global computer aided diagnostics (CAD) market.

The following key questions have been addressed in the report:

  • What are the major market drivers, challenges and opportunities of the global computer aided diagnostics market?
  • How the global computer aided diagnostics (CAD) market is evolving during the forecast period?
  • What are the driving and restraining factors in the global computer aided diagnostics (CAD) market?
  • What are the market shares of the leading segments and sub-segments of the global computer aided diagnostics (CAD) market in 2016 and 2025?
  • How will each segment of the computer aided diagnostics (CAD) market grow over the forecast period and how much revenue will these account for in 2025?
  • How will the market share of the leading companies change in 2017 and which country will lead the market in 2017?
  • How will the industry evolve during the forecast period between 2017 and 2025?
  • What are the key developmental strategies implemented in different types across all regions?
  • Which geographical region will lead the global computer aided diagnostics market by the end of the forecast period?
  • What are the market trends and key developments in this market?

The report includes the profiles of the major players in the market that allows the readers to get an insight into the various industry trends. Some of the leading companies in the market are iCAD Inc., Hologic Inc., EDDA Technology, Inc., GE Healthcare, Merge Healthcare Inc., Siemens Healthcare, Agfa-Gevaert N.V., Fujifilm Medical Systems, Philips Healthcare, Samsung Medison, Neusoft Corporation, Invivo Corporation, Cadens Medical Imaging, Riverain technologies, Median Technologies and McKesson Corporation.

Table of Contents

Executive Summary

1. Report Scope and Methodology

  • 1.1. Scope of the Report
  • 1.2. Global Computer Aided Diagnostics Market Segmentation
  • 1.3. Key Learnings
  • 1.4. Research Methodology
    • 1.4.1. Data Triangulation
    • 1.4.2. Key Data Points From Secondary Sources
    • 1.4.3. Key Data Points From Primary Sources
    • 1.4.4. Top-Down Approach (Segmental Analysis)
    • 1.4.5. Bottom-Up Approach (Segmental Analysis)
    • 1.4.6. Assumption and Limitations
    • 1.4.7. Data and Prediction Modelling

2. Market Overview

  • 2.1. Introduction
  • 2.2. Market Trend
  • 2.3. Evaluation method for CAD
  • 2.4. Involvement of Deep Learning in CADx
  • 2.5. CADx Deep Learning need in Radiology
  • 2.6. Advantages of Computer Aided Diagnostics
  • 2.7. Some Restraining Factors in Widespread Adoption of CADx Deep Learning Algorithm
  • 2.8. CADx-Recent Developments

3. Market Dynamics

  • 3.1. Overview
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Market Challenges
  • 3.5. Market Opportunities

4. Competitive Landscape

  • 4.1. Key Market Development Snapshot
    • 4.1.1. New Product Launches, Developments and Testing
    • 4.1.2. Patents, Approvals and Certifications
    • 4.1.3. Mergers and Acquisitions
    • 4.1.4. Collaborations, Joint Ventures & Partnerships
    • 4.1.5. Business Expansion
    • 4.1.6. Others Strategies
  • 4.2. Technological Trend
  • 4.3. Legal Requirements and Regulations
  • 4.4. Supply Chain Analysis

5. Industry Insights

  • 5.1. Patent Landscape
  • 5.2. Consortiums, Associations and Regulatory Bodies

6. Global CADx Market by Applications

  • 6.1. Overview
  • 6.2. Oncology
    • 6.2.1. Breast Cancer
    • 6.2.2. Lung Cancer
    • 6.2.3. Colorectal Cancer
    • 6.2.4. Prostate Cancer
    • 6.2.5. Liver Cancer
    • 6.2.6. Other Cancers
  • 6.3. Other Diseases

7. Global CADx Market by Imaging Modalities

  • 7.1. Overview
  • 7.2. Mammography
  • 7.3. Magnetic Resonance Imaging (MRI)
  • 7.4. Ultrasound
  • 7.5. Tomosynthesis
  • 7.6. Computed Tomography (CT)
  • 7.7. Others

8. Global CADx Market by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. The U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. The U.K.
    • 8.3.2. Germany
    • 8.3.3. France
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Poland
    • 8.3.7. Netherlands
    • 8.3.8. Switzerland
    • 8.3.9. Austria
    • 8.3.10. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. South Korea
    • 8.4.4. Australia
    • 8.4.5. India
    • 8.4.6. Rest of APAC
  • 8.5. RoW
    • 8.5.1. Brazil
    • 8.5.2. Russia
    • 8.5.3. Others

9. Company Profiles

  • 9.1. Cadens Medical Imaging
    • 9.1.1. Overview
    • 9.1.2. Product Mapping
    • 9.1.3. Financials
      • 9.1.3.1. Financial Summary
    • 9.1.4. SWOT Analysis
  • 9.2. EDDA Technology, Inc.
    • 9.2.1. Overview
    • 9.2.2. Product Mapping
    • 9.2.3. Overall Summary
    • 9.2.4. SWOT Analysis
  • 9.3. Fujifilm Holdings Corporation
    • 9.3.1. Overview
    • 9.3.2. Product Mapping
    • 9.3.3. Financials
      • 9.3.3.1. Financial Summary
  • 9.4. GE Healthcare
    • 9.4.1. Overview
    • 9.4.2. Financials
      • 9.4.2.1. Financial Summary
    • 9.4.3. SWOT Analysis
  • 9.5. Hologic Inc.
    • 9.5.1. Overview
    • 9.5.2. Product Mapping
    • 9.5.3. Financials
      • 9.5.3.1. Financial Summary
    • 9.5.4. SWOT Analysis
  • 9.6. iCAD Inc.
    • 9.6.1. Overview
    • 9.6.2. Product Mapping
    • 9.6.3. Financials
      • 9.6.3.1. Financial Summary
    • 9.6.4. SWOT Analysis
  • 9.7. Invivo Corporation
    • 9.7.1. Overview
    • 9.7.2. Product Mapping
    • 9.7.3. SWOT Analysis
  • 9.8. Koninklijke Philips N.V.
    • 9.8.1. Overview
    • 9.8.2. Product Mapping
    • 9.8.3. Financials
      • 9.8.3.1. Financial Summary
    • 9.8.4. SWOT Analysis
  • 9.9. Median Technologies
    • 9.9.1. Overview
    • 9.9.2. Product Mapping
    • 9.9.3. Financials
      • 9.9.3.1. Financial Summary
    • 9.9.4. SWOT Analysis
  • 9.10. Merge Healthcare Inc.
    • 9.10.1. Overview
    • 9.10.2. Product Mapping
    • 9.10.3. Financials
      • 9.10.3.1. Financial Summary
    • 9.10.4. SWOT Analysis
  • 9.11. Neusoft Corporation
    • 9.11.1. Overview
    • 9.11.2. Product Mapping
    • 9.11.3. Financials
      • 9.11.3.1. Financial Summary
    • 9.11.4. SWOT Analysis
  • 9.12. Parascript LLC
    • 9.12.1. Overview
    • 9.12.2. Product Mapping
    • 9.12.3. Overall Summary
    • 9.12.4. SWOT Analysis
  • 9.13. Riverain Technologies
    • 9.13.1. Overview
    • 9.13.2. Product Mapping
    • 9.13.3. Overall Summary
    • 9.13.4. SWOT Analysis
  • 9.14. Samsung Medison Co. Ltd.
    • 9.14.1. Overview
    • 9.14.2. Product Mapping
    • 9.14.3. Financials
      • 9.14.3.1. Financial Summary
    • 9.14.4. SWOT Analysis
  • 9.15. Siemens Healthineers
    • 9.15.1. Overview
    • 9.15.2. Product Mapping
    • 9.15.3. Overall Summary
    • 9.15.4. SWOT Analysis
  • 9.16. Agfa Healthcare
    • 9.16.1. Overview
  • 9.17. McKesson Corporation
    • 9.17.1. Overview
  • 9.18. Xinapse Systems Ltd
    • 9.18.1. Overview
Back to Top